Found: 2
Select item for more details and to access through your institution.
ATHENA: A Phase 3, Open-Label Study Of The Safety And Effectiveness Of Oliceridine (TRV130), A G-Protein Selective Agonist At The μ-Opioid Receptor, In Patients With Moderate To Severe Acute Pain Requiring Parenteral Opioid Therapy.
- Published in:
- Journal of Pain Research, 2019, v. 12, p. 3113, doi. 10.2147/JPR.S217563
- By:
- Publication type:
- Article
Low Incidence of Opioid-Induced Respiratory Depression Observed with Oliceridine Regardless of Age or Body Mass Index: Exploratory Analysis from a Phase 3 Open-Label Trial in Postsurgical Pain.
- Published in:
- Pain & Therapy, 2021, v. 10, n. 1, p. 457, doi. 10.1007/s40122-020-00232-x
- By:
- Publication type:
- Article